Dow reaches 48K level for the first time since Nov. after FOMC cuts 25 bps
Seeking Alpha News (Wed, 10-Dec 4:10 PM ET)
Dow, S&P 500 rise as FOMC cuts 25 basis points with 3 dissents
Seeking Alpha News (Wed, 10-Dec 2:14 PM ET)
Dow jumps as investors await Federal Reserve's rate decision
Seeking Alpha News (Wed, 10-Dec 1:30 PM ET)
Dow jumps, S&P 500 advances as investors await Fed's rate decision
Seeking Alpha News (Wed, 10-Dec 1:15 PM ET)
Wall Street searches for guidance as investors await Fed's rate decision
Seeking Alpha News (Wed, 10-Dec 10:18 AM ET)
Stocks open slightly lower as all eyes turn to Fed decision
Seeking Alpha News (Wed, 10-Dec 9:35 AM ET)
Stock index futures tread water as all eyes turn to Fed decision
Seeking Alpha News (Wed, 10-Dec 8:48 AM ET)
Stock index futures, yields tread water with Fed decision in view
Seeking Alpha News (Wed, 10-Dec 5:39 AM ET)
Analysts Offer Insights on Healthcare Companies: CVS Health (CVS) and Resmed (RMD)
TipRanks (Wed, 10-Dec 5:30 AM ET)
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Resmed trades on the NYSE stock market under the symbol RMD.
As of December 11, 2025, RMD stock price climbed to $252.39 with 707,948 million shares trading.
RMD has a beta of 0.67, meaning it tends to be less sensitive to market movements. RMD has a correlation of 0.27 to the broad based SPY ETF.
RMD has a market cap of $36.84 billion. This is considered a Large Cap stock.
Last quarter Resmed reported $1 billion in Revenue and $2.55 earnings per share. This beat revenue expectation by $8 million and exceeded earnings estimates by $.05.
In the last 3 years, RMD traded as high as $293.81 and as low as $132.24.
The top ETF exchange traded funds that RMD belongs to (by Net Assets): VTI, VOO, VO, VUG, SPY.
RMD has underperformed the market in the last year with a price return of +3.8% while the SPY ETF gained +15.5%. RMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -6.5% and -1.0%, respectively, while the SPY returned +5.9% and +1.4%, respectively.
RMD support price is $246.79 and resistance is $256.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RMD shares will trade within this expected range on the day.
